Statement of Ownership (sc 13g)
June 25 2015 - 3:06PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
ARCA
biopharma, Inc.
(Name of Issuer)
Common stock
(Title of
Class of Securities)
00211Y100
(CUSIP Number)
June 16,
2015
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
¨ Rule 13d-1(b)
x Rule 13d-1(c)
¨ Rule 13d-1(d)
| * |
The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information
which would alter disclosures provided in a prior cover page. |
The information required on the remainder of this cover page
shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the
Act (however, see the Notes).
SCHEDULE 13G
|
|
|
| CUSIP No. 00211Y100 |
|
Page 2 of 15 Pages |
|
|
|
|
|
|
|
| 1 |
|
Names of
reporting persons. I.R.S. Identification Nos. of above persons (entities only)
Venrock Healthcare Capital Partners, L.P. |
| 2 |
|
Check the appropriate box if a member
of a group (see instructions)
(a) x1
(b) ¨ |
| 3 |
|
SEC use only
|
| 4 |
|
Citizenship or place of
organization Delaware |
| Number of
shares beneficially
owned by each
reporting person
with |
|
5 |
|
Sole voting power
0 |
|
6 |
|
Shared voting power
10,789,3242 |
|
7 |
|
Sole dispositive power
0 |
|
8 |
|
Shared dispositive power
10,789,3242 |
| 9 |
|
Aggregate amount beneficially owned by each reporting person
10,789,3242 |
| 10 |
|
Check if the aggregate amount in Row
(9) excludes certain shares (see instructions)
N/A |
| 11 |
|
Percent of class represented by amount
in Row (9)
17.1%3 |
| 12 |
|
Type of reporting person (see
instructions) PN |
| 1. |
Venrock Healthcare Capital Partners, L.P. (“VHCP”); Venrock Healthcare Capital Partners II, L.P. (“VHCP II”); VCHP Co-Investment Holdings, LLC (“Co-Invest”); VHCP Co-Investment Holdings II,
LLC (“Co-Invest II”); VCHP Management, LLC; VCHP Management II, LLC; Anders Hove and Bong Koh are members of a group for the purposes of this Schedule 13G. |
| 2. |
Consists of: 2,736,388 shares of common stock held directly by VHCP; 5,373,623 shares of common stock held directly by VHCP II; 500,409 shares of common stock held directly by Co-Invest; and 2,178,904 shares of common
stock held directly by Co-Invest II. |
| 3. |
This percentage is calculated based upon the number of the Issuer’s total outstanding shares equal to the sum of (i) 21,198,411 shares of the Issuer’s common stock outstanding as of May 11, 2015, as set forth
in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 12, 2015 and (ii) 42,021,579 shares of common stock issued on June 16, 2015. |
SCHEDULE 13G
|
|
|
| CUSIP No. 00211Y100 |
|
Page 3 of 15 Pages |
|
|
|
|
|
|
|
| 1 |
|
Names of
reporting persons. I.R.S. Identification Nos. of above persons (entities only)
Venrock Healthcare Capital Partners II, L.P. |
| 2 |
|
Check the appropriate box if a member
of a group (see instructions)
(a) x1
(b) ¨ |
| 3 |
|
SEC use only
|
| 4 |
|
Citizenship or place of
organization Delaware |
| Number of
shares beneficially
owned by each
reporting person
with |
|
5 |
|
Sole voting power
0 |
|
6 |
|
Shared voting power
10,789,3242 |
|
7 |
|
Sole dispositive power
0 |
|
8 |
|
Shared dispositive power
10,789,3242 |
| 9 |
|
Aggregate amount beneficially owned by each reporting person
10,789,3242 |
| 10 |
|
Check if the aggregate amount in Row
(9) excludes certain shares (see instructions)
N/A |
| 11 |
|
Percent of class represented by amount
in Row (9)
17.1%3 |
| 12 |
|
Type of reporting person (see
instructions) PN |
| 1. |
Venrock Healthcare Capital Partners, L.P. (“VHCP”); Venrock Healthcare Capital Partners II, L.P. (“VHCP II”); VCHP Co-Investment Holdings, LLC (“Co-Invest”); VHCP Co-Investment Holdings II,
LLC (“Co-Invest II”); VCHP Management, LLC; VCHP Management II, LLC; Anders Hove and Bong Koh are members of a group for the purposes of this Schedule 13G. |
| 2. |
Consists of: 2,736,388 shares of common stock held directly by VHCP; 5,373,623 shares of common stock an held directly by VHCP II; 500,409 shares of common stock held directly by Co-Invest; and 2,178,904 shares of
common stock held directly by Co-Invest II. |
| 3. |
This percentage is calculated based upon the number of the Issuer’s total outstanding shares equal to the sum of (i) 21,198,411 shares of the Issuer’s common stock outstanding as of May 11, 2015, as set forth
in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 12, 2015 and (ii) 42,021,579 shares of common stock issued on June 16, 2015. |
SCHEDULE 13G
|
|
|
| CUSIP No. 00211Y100 |
|
Page 4 of 15 Pages |
|
|
|
|
|
|
|
| 1 |
|
Names of
reporting persons. I.R.S. Identification Nos. of above persons (entities only)
VHCP Co-Investment Holdings, LLC |
| 2 |
|
Check the appropriate box if a member
of a group (see instructions)
(a) x1
(b) ¨ |
| 3 |
|
SEC use only
|
| 4 |
|
Citizenship or place of
organization Delaware |
| Number of
shares beneficially
owned by each
reporting person
with |
|
5 |
|
Sole voting power
0 |
|
6 |
|
Shared voting power
10,789,3242 |
|
7 |
|
Sole dispositive power
0 |
|
8 |
|
Shared dispositive power
10,789,3242 |
| 9 |
|
Aggregate amount beneficially owned by each reporting person
10,789,3242 |
| 10 |
|
Check if the aggregate amount in Row
(9) excludes certain shares (see instructions)
N/A |
| 11 |
|
Percent of class represented by amount
in Row (9)
17.1%3 |
| 12 |
|
Type of reporting person (see
instructions) OO |
| 1. |
Venrock Healthcare Capital Partners, L.P. (“VHCP”); Venrock Healthcare Capital Partners II, L.P. (“VHCP II”); VCHP Co-Investment Holdings, LLC (“Co-Invest”); VHCP Co-Investment Holdings II,
LLC (“Co-Invest II”); VCHP Management, LLC; VCHP Management II, LLC, Anders Hove and Bong Koh are members of a group for the purposes of this Schedule 13G. |
| 2. |
Consists of: 2,736,388 shares of common stock held directly by VHCP; 5,373,623 shares of common stock held directly by VHCP II; 500,409 shares of common stock held directly by Co-Invest; and 2,178,904 shares of common
stock held directly by Co-Invest II. |
| 3. |
This percentage is calculated based upon the number of the Issuer’s total outstanding shares equal to the sum of (i) 21,198,411 shares of the Issuer’s common stock outstanding as of May 11, 2015, as set forth
in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 12, 2015 and (ii) 42,021,579 shares of common stock issued on June 16, 2015. |
SCHEDULE 13G
|
|
|
| CUSIP No. 00211Y100 |
|
Page 5 of 15 Pages |
|
|
|
|
|
|
|
| 1 |
|
Names of
reporting persons. I.R.S. Identification Nos. of above persons (entities only)
VHCP Co-Investment Holdings II, LLC |
| 2 |
|
Check the appropriate box if a member
of a group (see instructions)
(a) x1
(b) ¨ |
| 3 |
|
SEC use only
|
| 4 |
|
Citizenship or place of
organization Delaware |
| Number of
shares beneficially
owned by each
reporting person
with |
|
5 |
|
Sole voting power
0 |
|
6 |
|
Shared voting power
10,789,3242 |
|
7 |
|
Sole dispositive power
0 |
|
8 |
|
Shared dispositive power
10,789,3242 |
| 9 |
|
Aggregate amount beneficially owned by each reporting person
10,789,3242 |
| 10 |
|
Check if the aggregate amount in Row
(9) excludes certain shares (see instructions)
N/A |
| 11 |
|
Percent of class represented by amount
in Row (9)
17.1%3 |
| 12 |
|
Type of reporting person (see
instructions) OO |
| 1. |
Venrock Healthcare Capital Partners, L.P. (“VHCP”); Venrock Healthcare Capital Partners II, L.P. (“VHCP II”); VCHP Co-Investment Holdings, LLC (“Co-Invest”); VHCP Co-Investment Holdings II,
LLC (“Co-Invest II”); VCHP Management, LLC; VCHP Management II, LLC; Anders Hove and Bong Koh are members of a group for the purposes of this Schedule 13G. |
| 2. |
Consists of: 2,736,388 shares of common stock held directly by VHCP; 5,373,623 shares of common stock held directly by VHCP II; 500,409 shares of common stock held directly by Co-Invest; and 2,178,904 shares of common
stock held directly by Co-Invest II. |
| 3. |
This percentage is calculated based upon the number of the Issuer’s total outstanding shares equal to the sum of (i) 21,198,411 shares of the Issuer’s common stock outstanding as of May 11, 2015, as set forth
in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 12, 2015 and (ii) 42,021,579 shares of common stock issued on June 16, 2015. |
|
|
|
| CUSIP No. 00211Y100 |
|
Page 6 of 15 Pages |
|
|
|
|
|
|
|
| 1 |
|
Names of
reporting persons. I.R.S. Identification Nos. of above persons (entities only)
VHCP Management, LLC |
| 2 |
|
Check the appropriate box if a member
of a group (see instructions)
(a) x1
(b) ¨ |
| 3 |
|
SEC use only
|
| 4 |
|
Citizenship or place of
organization Delaware |
| Number of
shares beneficially
owned by each
reporting person
with |
|
5 |
|
Sole voting power
0 |
|
6 |
|
Shared voting power
10,789,3242 |
|
7 |
|
Sole dispositive power
0 |
|
8 |
|
Shared dispositive power
10,789,3242 |
| 9 |
|
Aggregate amount beneficially owned by each reporting person
10,789,3242 |
| 10 |
|
Check if the aggregate amount in Row
(9) excludes certain shares (see instructions)
N/A |
| 11 |
|
Percent of class represented by amount
in Row (9)
17.1%3 |
| 12 |
|
Type of reporting person (see
instructions) OO |
| 1. |
Venrock Healthcare Capital Partners, L.P. (“VHCP”); Venrock Healthcare Capital Partners II, L.P. (“VHCP II”); VCHP Co-Investment Holdings, LLC (“Co-Invest”); VHCP Co-Investment Holdings II,
LLC (“Co-Invest II”); VCHP Management, LLC; VCHP Management II, LLC; Anders Hove and Bong Koh are members of a group for the purposes of this Schedule 13G. |
| 2. |
Consists of: 2,736,388 shares of common stock held directly by VHCP; 5,373,623 shares of common stock held directly by VHCP II; 500,409 shares of common stock held directly by Co-Invest; and 2,178,904 shares of common
stock held directly by Co-Invest II. |
| 3. |
This percentage is calculated based upon the number of the Issuer’s total outstanding shares equal to the sum of (i) 21,198,411 shares of the Issuer’s common stock outstanding as of May 11, 2015, as set forth
in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 12, 2015 and (ii) 42,021,579 shares of common stock issued on June 16, 2015 |
|
|
|
| CUSIP No. 00211Y100 |
|
Page 7 of 15 Pages |
|
|
|
|
|
|
|
| 1 |
|
Names of
reporting persons. I.R.S. Identification Nos. of above persons (entities only)
VHCP Management II, LLC |
| 2 |
|
Check the appropriate box if a member
of a group (see instructions)
(a) x1
(b) ¨ |
| 3 |
|
SEC use only
|
| 4 |
|
Citizenship or place of
organization Delaware |
| Number of
shares beneficially
owned by each
reporting person
with |
|
5 |
|
Sole voting power
0 |
|
6 |
|
Shared voting power
10,789,3242 |
|
7 |
|
Sole dispositive power
0 |
|
8 |
|
Shared dispositive power
10,789,3242 |
| 9 |
|
Aggregate amount beneficially owned by each reporting person
10,789,3242 |
| 10 |
|
Check if the aggregate amount in Row
(9) excludes certain shares (see instructions)
N/A |
| 11 |
|
Percent of class represented by amount
in Row (9)
17.1%3 |
| 12 |
|
Type of reporting person (see
instructions) OO |
| 1. |
Venrock Healthcare Capital Partners, L.P. (“VHCP”); Venrock Healthcare Capital Partners II, L.P. (“VHCP II”); VCHP Co-Investment Holdings, LLC (“Co-Invest”); VHCP Co-Investment Holdings II,
LLC (“Co-Invest II”); VCHP Management, LLC; VCHP Management II, LLC; Anders Hove and Bong Koh are members of a group for the purposes of this Schedule 13G. |
| 2. |
Consists of: 2,736,388 shares of common stock held directly by VHCP; 5,373,623 shares of common stock held directly by VHCP II; 500,409 shares of common stock held directly by Co-Invest; and 2,178,904 shares of common
stock held directly by Co-Invest II. |
| 3. |
This percentage is calculated based upon the number of the Issuer’s total outstanding shares equal to the sum of (i) 21,198,411 shares of the Issuer’s common stock outstanding as of May 11, 2015, as set forth
in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 12, 2015 and (ii) 42,021,579 shares of common stock issued on June 16, 2015. |
SCHEDULE 13G
|
|
|
| CUSIP No. 00211Y100 |
|
Page 8 of 15 Pages |
|
|
|
|
|
|
|
| 1 |
|
Names of
reporting persons. I.R.S. Identification Nos. of above persons (entities only)
Koh, Bong |
| 2 |
|
Check the appropriate box if a member
of a group (see instructions)
(a) x1
(b) ¨ |
| 3 |
|
SEC use only
|
| 4 |
|
Citizenship or place of
organization United States |
| Number of
shares beneficially
owned by each
reporting person
with |
|
5 |
|
Sole voting power
0 |
|
6 |
|
Shared voting power
10,789,3242 |
|
7 |
|
Sole dispositive power
0 |
|
8 |
|
Shared dispositive power
10,789,3242 |
| 9 |
|
Aggregate amount beneficially owned by each reporting person
10,789,3242 |
| 10 |
|
Check if the aggregate amount in Row
(9) excludes certain shares (see instructions)
N/A |
| 11 |
|
Percent of class represented by amount
in Row (9)
17.1%3 |
| 12 |
|
Type of reporting person (see
instructions) IN |
| 1. |
Venrock Healthcare Capital Partners, L.P. (“VHCP”); Venrock Healthcare Capital Partners II, L.P. (“VHCP II”); VCHP Co-Investment Holdings, LLC (“Co-Invest”); VHCP Co-Investment Holdings II,
LLC (“Co-Invest II”); VCHP Management, LLC; VCHP Management II, LLC; Anders Hove and Bong Koh are members of a group for the purposes of this Schedule 13G. |
| 2. |
Consists of: 2,736,388 shares of common stock held directly by VHCP; 5,373,623 shares of common stock held directly by VHCP II; 500,409 shares of common stock held directly by Co-Invest; and 2,178,904 shares of common
stock held directly by Co-Invest II. |
| 3. |
This percentage is calculated based upon the number of the Issuer’s total outstanding shares equal to the sum of (i) 21,198,411 shares of the Issuer’s common stock outstanding as of May 11, 2015, as set forth
in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 12, 2015 and (ii) 42,021,579 shares of common stock issued on June 16, 2015. |
SCHEDULE 13G
|
|
|
| CUSIP No. 00211Y100 |
|
Page 9 of 15 Pages |
|
|
|
|
|
|
|
| 1 |
|
Names of
reporting persons. I.R.S. Identification Nos. of above persons (entities only)
Hove, Anders |
| 2 |
|
Check the appropriate box if a member
of a group (see instructions)
(a) x1
(b) ¨ |
| 3 |
|
SEC use only
|
| 4 |
|
Citizenship or place of
organization United States |
| Number of
shares beneficially
owned by each
reporting person
with |
|
5 |
|
Sole voting power
0 |
|
6 |
|
Shared voting power
10,789,3242 |
|
7 |
|
Sole dispositive power
0 |
|
8 |
|
Shared dispositive power
10,789,3242 |
| 9 |
|
Aggregate amount beneficially owned by each reporting person
10,789,3242 |
| 10 |
|
Check if the aggregate amount in Row
(9) excludes certain shares (see instructions)
N/A |
| 11 |
|
Percent of class represented by amount
in Row (9)
17.1%3 |
| 12 |
|
Type of reporting person (see
instructions) IN |
| 1. |
Venrock Healthcare Capital Partners, L.P. (“VHCP”); Venrock Healthcare Capital Partners II, L.P. (“VHCP II”); VCHP Co-Investment Holdings, LLC (“Co-Invest”); VHCP Co-Investment Holdings II,
LLC (“Co-Invest II”); VCHP Management, LLC; VCHP Management II, LLC; Anders Hove and Bong Koh are members of a group for the purposes of this Schedule 13G. |
| 2. |
Consists of: 2,736,388 shares of common stock held directly by VHCP; 5,373,623 shares of common stock held directly by VHCP II; 500,409 shares of common stock held directly by Co-Invest; and 2,178,904 shares of common
stock held directly by Co-Invest II. |
| 3. |
This percentage is calculated based upon the number of the Issuer’s total outstanding shares equal to the sum of (i) 21,198,411 shares of the Issuer’s common stock outstanding as of May 11, 2015, as set forth
in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on May 12, 2015 and (ii) 42,021,579 shares of common stock issued on June 16, 2015. |
SCHEDULE 13G
|
|
|
| CUSIP No. 00211Y100 |
|
Page
10
of 15 Pages |
Introductory Note: This Schedule 13G is filed on behalf of Venrock Healthcare Capital Partners, L.P., a
limited partnership organized under the laws of the state of Delaware, Venrock Capital Partners II, L.P., a limited partnership organized under the laws of the state of Delaware, VCHP Co-Investment Holdings, LLC., a limited liability company
organized under the laws of the state of Delaware, VHCP Co-Investment Holdings II, LLC, a limited liability company organized under the laws of the state of Delaware, VCHP Management, LLC, a limited liability company organized under the laws of the
state of Delaware, VCHP Management II, LLC, a limited liability company organized under the laws of the state of Delaware, Anders Hove and Bong Koh in respect of the shares of common stock of ARCA biopharma, Inc.
Item 1.
ARCA biopharma, Inc.
| |
(b) |
Address of Issuer’s Principal Executive Offices: |
11080 CirclePoint Road, Suite 140
Westminster, CO 80020
Item 2.
| |
(a) |
Name of Persons Filing: |
Venrock Healthcare Capital Partners, L.P.
Venrock Healthcare Capital Partners II, L.P.
VHCP Co-Investment Holdings, LLC
VHCP Co-Investment Holdings II, LLC
VHCP Management, LLC
VHCP
Management II, LLC
Anders Hove
Bong Koh
| |
(b) |
Address of Principal Business Office or, if none, Residence: |
|
|
|
|
|
| New York Office |
|
Palo Alto Office |
|
Cambridge Office |
|
|
|
| 530 Fifth Avenue |
|
3340 Hillview Avenue |
|
55 Cambridge Parkway |
| 22nd Floor |
|
Palo Alto, CA 94304 |
|
Suite 100 |
| New York, NY 10036 |
|
|
|
Cambridge MA, 02142 |
|
|
|
| CUSIP No. 00211Y100 |
|
Page
11
of 15 Pages |
All entities are organized in Delaware. The individuals are both United
States citizens.
| |
(d) |
Title of Class of Securities: |
Common Stock
00211Y100
| Item 3: |
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
Not applicable.
SCHEDULE 13G
|
|
|
| CUSIP No. 00211Y100 |
|
Page
12
of 15 Pages |
| |
(a) |
Amount beneficially owned as of June 16, 2015: |
|
|
|
|
|
| Venrock Healthcare Capital Partners, L.P. |
|
|
10,789,324 |
(1) |
| Venrock Healthcare Capital Partners II, L.P. |
|
|
10,789,324 |
(1) |
| VHCP Co-Investment Holdings, LLC |
|
|
10,789,324 |
(1) |
| VHCP Co-Investment Holdings, LLC |
|
|
10,789,324 |
(1) |
| VHCP Management, LLC |
|
|
10,789,324 |
(1) |
| VHCP Management II, LLC |
|
|
10,789,324 |
(1) |
| Anders Hove |
|
|
10,789,324 |
(1) |
| Bong Koh |
|
|
10,789,324 |
(1) |
| |
(b) |
Percent of class as of June 16, 2015: |
|
|
|
|
|
| Venrock Healthcare Capital Partners, L.P. |
|
|
17.1 |
% |
| Venrock Healthcare Capital Partners II, L.P. |
|
|
17.1 |
% |
| VHCP Co-Investment Holdings, LLC |
|
|
17.1 |
% |
| VHCP Co-Investment Holdings II, LLC |
|
|
17.1 |
% |
| VHCP Management, LLC |
|
|
17.1 |
% |
| VHCP Management II, LLC |
|
|
17.1 |
% |
| Anders Hove |
|
|
17.1 |
% |
| Bong Koh |
|
|
17.1 |
% |
| |
(c) |
Number of shares to which the person has as of June 16, 2015: |
| |
(i) |
Sole power to vote or to direct the vote: |
|
|
|
|
|
| Venrock Healthcare Capital Partners, L.P. |
|
|
0 |
|
| Venrock Healthcare Capital Partners II, L.P. |
|
|
0 |
|
| VHCP Co-Investment Holdings, LLC |
|
|
0 |
|
| VHCP Co-Investment Holdings II, LLC |
|
|
0 |
|
| VHCP Management, LLC |
|
|
0 |
|
| VHCP Management II, LLC |
|
|
0 |
|
| Anders Hove |
|
|
0 |
|
| Bong Koh |
|
|
0 |
|
|
|
|
| CUSIP No. 00211Y100 |
|
Page
13
of 15 Pages |
| |
(ii) |
Shared power to vote or to direct the vote: |
|
|
|
|
|
| Venrock Healthcare Capital Partners, L.P. |
|
|
10,789,324 |
(1) |
| Venrock Healthcare Capital Partners II, L.P. |
|
|
10,789,324 |
(1) |
| VHCP Co-Investment Holdings, LLC |
|
|
10,789,324 |
(1) |
| VHCP Co-Investment Holdings II, LLC |
|
|
10,789,324 |
(1) |
| VHCP Management, LLC |
|
|
10,789,324 |
(1) |
| VHCP Management II, LLC |
|
|
10,789,324 |
(1) |
| Anders Hove |
|
|
10,789,324 |
(1) |
| Bong Koh |
|
|
10,789,324 |
(1) |
| |
(iii) |
Sole power to dispose or to direct the disposition of: |
|
|
|
|
|
| Venrock Healthcare Capital Partners, L.P. |
|
|
0 |
|
| Venrock Healthcare Capital Partners II, L.P. |
|
|
0 |
|
| VHCP Co-Investment Holdings, LLC |
|
|
0 |
|
| VHCP Co-Investment Holdings II, LLC |
|
|
0 |
|
| VHCP Management, LLC |
|
|
0 |
|
| VHCP Management II, LLC |
|
|
0 |
|
| Anders Hove |
|
|
0 |
|
| Bong Koh |
|
|
0 |
|
| |
(iv) |
Shared power to dispose or to direct the disposition of: |
|
|
|
|
|
| Venrock Healthcare Capital Partners, L.P. |
|
|
10,789,324 |
(1) |
| Venrock Healthcare Capital Partners II, L.P. |
|
|
10,789,324 |
(1) |
| VHCP Co-Investment Holdings, LLC |
|
|
10,789,324 |
(1) |
| VHCP Co-Investment Holdings II, LLC |
|
|
10,789,324 |
(1) |
| VHCP Management, LLC |
|
|
10,789,324 |
(1) |
| VHCP Management II, LLC |
|
|
10,789,324 |
(1) |
| Anders Hove |
|
|
10,789,324 |
(1) |
| Bong Koh |
|
|
10,789,324 |
(1) |
| (1) |
These shares are owned directly as follows: 2,736,388 shares of common stock are owned by Venrock Healthcare Capital Partners, L.P. (“VHCP”); 5,373,623 shares of common stock are owned by Venrock Healthcare
Capital Partners II, L.P. (“VHCP II”); 500,409 shares of common stock are owned by VHCP Co-Investment Holdings, LLC (“Co-Invest”); and 2,178,904 shares of common stock are owned by VHCP Co-Investment Holdings II, LLC
(“Co-Invest II”). VHCP Management, LLC is the general partner of VHCP and the manager of Co-Invest. VHCP Management II, LLC is the general partner of VHCP II and the manager of Co-Invest II. Messrs. Hove and Koh are the managing members of
VHCP Management, LLC and VHCP Management II, LLC. |
| Item 5. |
Ownership of Five Percent or Less of Class: |
If this statement is being filed to report the fact that as
of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ¨
SCHEDULE 13G
|
|
|
| CUSIP No. 00211Y100 |
|
Page
14
of 15 Pages |
| Item 6. |
Ownership of More than Five Percent on Behalf of Another Person: |
Not applicable.
| Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company: |
Not applicable.
| Item 8. |
Identification and Classification of Members of the Group: |
Not applicable.
| Item 9. |
Notice of Dissolution of Group: |
Not applicable.
By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.
SCHEDULE 13G
|
|
|
| CUSIP No. 00211Y100 |
|
Page
15
of 15 Pages |
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
Date: June 25, 2015
|
|
|
|
|
|
|
|
|
|
|
|
|
| Venrock Healthcare Capital Partners, L.P. |
|
|
|
Venrock Healthcare Capital Partners II, L.P. |
|
|
|
|
|
| By: |
|
VHCP Management, LLC |
|
|
|
By: |
|
VHCP Management II, LLC |
| Its: |
|
Manager |
|
|
|
Its: |
|
General Partner |
|
|
|
|
|
| By: |
|
/s/ David L. Stepp |
|
|
|
By: |
|
/s/ David L. Stepp |
|
|
Name: |
|
David L. Stepp |
|
|
|
|
|
Name: |
|
David L. Stepp |
|
|
Its: |
|
Authorized Signatory |
|
|
|
|
|
Its: |
|
Authorized Signatory |
|
|
|
| VHCP Co-Investment Holdings, LLC |
|
|
|
VHCP Co-Investment Holdings II, LLC |
|
|
|
|
|
| By: |
|
VHCP Management, LLC |
|
|
|
By: |
|
VHCP Management II, LLC |
| Its: |
|
Manager |
|
|
|
Its: |
|
General Partner |
|
|
|
|
|
| By: |
|
/s/ David L. Stepp |
|
|
|
By: |
|
/s/ David L. Stepp |
|
|
Name: |
|
David L. Stepp |
|
|
|
|
|
Name: |
|
David L. Stepp |
|
|
Its: |
|
Authorized Signatory |
|
|
|
|
|
Its: |
|
Authorized Signatory |
|
|
|
| VHCP Management, LLC |
|
|
|
VHCP Management II, LLC |
|
|
|
|
|
| By: |
|
/s/ David L. Stepp |
|
|
|
By: |
|
/s/ David L. Stepp |
|
|
Name: |
|
David L. Stepp |
|
|
|
|
|
Name: |
|
David L. Stepp |
|
|
Its: |
|
Authorized Signatory |
|
|
|
|
|
Its: |
|
Authorized Signatory |
|
|
|
| Anders Hove |
|
|
|
Bong Koh |
|
|
|
|
|
| By: |
|
/s/ David L. Stepp |
|
|
|
By: |
|
/s/ David L. Stepp |
|
|
David L. Stepp, as attorney-in-fact |
|
|
|
|
|
David L. Stepp, as attorney-in-fact |
EXHIBITS
| A: |
Joint Filing Agreement |
EXHIBIT A
JOINT FILING AGREEMENT
In
accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock
of ARCA biopharma, Inc. and further agree that this agreement be included as an exhibit to such filing. Each party to the agreement expressly authorizes each other party to file on its behalf any and all amendments to such statement. Each party to
this agreement agrees that this joint filing agreement may be signed in counterparts.
In evidence whereof, the undersigned have caused
this Agreement to be executed on their behalf this 25th day of June, 2015.
|
|
|
|
|
|
|
|
|
|
|
|
|
| Venrock Healthcare Capital Partners, L.P. |
|
|
|
Venrock Healthcare Capital Partners II, L.P. |
|
|
|
|
|
| By: |
|
VHCP Management, LLC |
|
|
|
By: |
|
VHCP Management II, LLC |
| Its: |
|
Manager |
|
|
|
Its: |
|
General Partner |
|
|
|
|
|
| By: |
|
/s/ David L. Stepp |
|
|
|
By: |
|
/s/ David L. Stepp |
|
|
Name: |
|
David L. Stepp |
|
|
|
|
|
Name: |
|
David L. Stepp |
|
|
Its: |
|
Authorized Signatory |
|
|
|
|
|
Its: |
|
Authorized Signatory |
|
|
|
| VHCP Co-Investment Holdings, LLC |
|
|
|
VHCP Co-Investment Holdings II, LLC |
|
|
|
|
|
| By: |
|
VHCP Management, LLC |
|
|
|
By: |
|
VHCP Management II, LLC |
| Its: |
|
Manager |
|
|
|
Its: |
|
General Partner |
|
|
|
|
|
| By: |
|
/s/ David L. Stepp |
|
|
|
By: |
|
/s/ David L. Stepp |
|
|
Name: |
|
David L. Stepp |
|
|
|
|
|
Name: |
|
David L. Stepp |
|
|
Its: |
|
Authorized Signatory |
|
|
|
|
|
Its: |
|
Authorized Signatory |
|
|
|
| VHCP Management, LLC |
|
|
|
VHCP Management II, LLC |
|
|
|
|
|
| By: |
|
/s/ David L. Stepp |
|
|
|
By: |
|
/s/ David L. Stepp |
|
|
Name: |
|
David L. Stepp |
|
|
|
|
|
Name: |
|
David L. Stepp |
|
|
Its: |
|
Authorized Signatory |
|
|
|
|
|
Its: |
|
Authorized Signatory |
|
|
|
| Anders Hove |
|
|
|
Bong Koh |
|
|
|
|
|
| By: |
|
/s/ David L. Stepp |
|
|
|
By: |
|
/s/ David L. Stepp |
|
|
David L. Stepp, as attorney-in-fact |
|
|
|
|
|
David L. Stepp, as attorney-in-fact |
ARCA Biopharma (NASDAQ:ABIO)
Historical Stock Chart
From Apr 2024 to May 2024
ARCA Biopharma (NASDAQ:ABIO)
Historical Stock Chart
From May 2023 to May 2024
